Drugs / FLU-v
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01181336 | Apr → Jul 2010 | influenza | PepTcell Limited | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLU-v | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01181336 ↗ |
| Modality | Vaccine | “novel synthetic Influenza vaccine (FLU-v)” PMID 22575166 ↗ May 2012 |
| Route | Subcutaneous | “Administration: A single subcutaneous injection” NCT01181336 ↗ |